Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F van Rhee

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Bone Marrow Transplantation|November 25, 1998
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporineR Childs, C Sanchez, H Engler, et al.
British Journal of Haematology|January 31, 1998
The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantationP Raanani, F Dazzi, J Sohal, et al.
Bone Marrow Transplantation|October 1, 1994
Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactionsA R Datta, A J Barrett, Y Z Jiang, et al.
Leukemia|January 18, 2008
Suppression of abnormal karyotype predicts superior survival in multiple myelomaV Arzoumanian, A Hoering, J Sawyer, et al.
Bone Marrow Transplantation|April 25, 2001
Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic responseL S Lamb, P Musk, Z Ye, et al.
Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.
Bone Marrow Transplantation|January 26, 2006
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantationC-K Lee, M Zangari, A Fassas, et al.
Leukemia|April 25, 2008
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myelomaM Pineda-Roman, M Zangari, F van Rhee, et al.
Bone Marrow Transplantation|January 10, 2001
Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosisS Singhal, A Safdar, K Y Chiang, et al.
Blood|June 1, 1994
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapseF van Rhee, F Lin, J O Cullis, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Bone Marrow Transplantation|November 25, 1998
High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporineR Childs, C Sanchez, H Engler, et al.
British Journal of Haematology|January 31, 1998
The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantationP Raanani, F Dazzi, J Sohal, et al.
Bone Marrow Transplantation|October 1, 1994
Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactionsA R Datta, A J Barrett, Y Z Jiang, et al.
Leukemia|January 18, 2008
Suppression of abnormal karyotype predicts superior survival in multiple myelomaV Arzoumanian, A Hoering, J Sawyer, et al.
Bone Marrow Transplantation|April 25, 2001
Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic responseL S Lamb, P Musk, Z Ye, et al.
Leukemia|February 1, 1995
Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrowF van Rhee, D I Marks, F Lin, et al.
Bone Marrow Transplantation|January 26, 2006
Clonal cytogenetic changes and myeloma relapse after reduced intensity conditioning allogeneic transplantationC-K Lee, M Zangari, A Fassas, et al.
Leukemia|April 25, 2008
VTD combination therapy with bortezomib-thalidomide-dexamethasone is highly effective in advanced and refractory multiple myelomaM Pineda-Roman, M Zangari, F van Rhee, et al.
Bone Marrow Transplantation|January 10, 2001
Non-myeloablative allogeneic transplantation ('microallograft') for refractory myeloma after two preceding autografts: feasibility and efficacy in a patient with active aspergillosisS Singhal, A Safdar, K Y Chiang, et al.
Blood|June 1, 1994
Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapseF van Rhee, F Lin, J O Cullis, et al.
Pageof 9